Low-Dose Adjuvant Aspirin Decreases Incidence of Recurrence Among Patients with Resected PI3K-Altered CRC By Ogkologos - September 30, 2025 296 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ALASCCA study Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Belzutifan with Pembrolizumab for Adjuvant Treatment of Renal Cell Carcinoma How Decades of NCI Support Led to Groundbreaking Discoveries: The Story of Immune Checkpoint Inhibitors Adding Belzutifan to Pembrolizumab Prolongs DFS After Nephrectomy in Patients with ccRCC at Increased Risk for Recurrence MOST POPULAR Women Experience More Side Effects from Pelvic Radiation than Realized April 8, 2020 Tackling under-representation of Black data scientists in cancer research November 7, 2022 Efficacy of Afamitresgene Autoleucel for HLA-A*02-positive and MAGE-A4-positive Synovial Sarcoma Following... April 2, 2024 FDA Approves Selinexor for Refractory or Relapsed Multiple Myeloma January 8, 2021 Load more HOT NEWS FDA Approves New Dosing Regimen for Cetuximab Hospital Mistakenly Gave Woman a Mastectomy, Then Postponed Her Reconstruction for... 细针穿刺活检：如何准备和会发生什么 Adagrasib Shows Clinical Efficacy in Patients with Previously Treated KRASG12C-Mutated Advanced...
